200 related articles for article (PubMed ID: 30229771)
1. Low-intensity focused ultrasound (LIFU)-activated nanodroplets as a theranostic agent for noninvasive cancer molecular imaging and drug delivery.
Liu J; Xu F; Huang J; Xu J; Liu Y; Yao Y; Ao M; Li A; Hao L; Cao Y; Hu Z; Ran H; Wang Z; Li P
Biomater Sci; 2018 Nov; 6(11):2838-2849. PubMed ID: 30229771
[TBL] [Abstract][Full Text] [Related]
2. Low-intensity focused ultrasound (LIFU)-induced acoustic droplet vaporization in phase-transition perfluoropentane nanodroplets modified by folate for ultrasound molecular imaging.
Liu J; Shang T; Wang F; Cao Y; Hao L; Ren J; Ran H; Wang Z; Li P; Du Z
Int J Nanomedicine; 2017; 12():911-923. PubMed ID: 28184161
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional Nanoparticles for Multimodal Imaging-Guided Low-Intensity Focused Ultrasound/Immunosynergistic Retinoblastoma Therapy.
Wang M; Yang Q; Li M; Zou H; Wang Z; Ran H; Zheng Y; Jian J; Zhou Y; Luo Y; Ran Y; Jiang S; Zhou X
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5642-5657. PubMed ID: 31940169
[TBL] [Abstract][Full Text] [Related]
4. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
[No Abstract] [Full Text] [Related]
5. A nanosystem loaded with perfluorohexane and rose bengal coupled upconversion nanoparticles for multimodal imaging and synergetic chemo-photodynamic therapy of cancer.
Wang HY; Hou L; Li HL; Wang X; Cao Y; Zhang BY; Wang JT; Wei SJ; Dang HW; Ran HT
Biomater Sci; 2020 May; 8(9):2488-2506. PubMed ID: 32211626
[TBL] [Abstract][Full Text] [Related]
6. Peptide-Functionalized Phase-Transformation Nanoparticles for Low Intensity Focused Ultrasound-Assisted Tumor Imaging and Therapy.
Zhu L; Zhao H; Zhou Z; Xia Y; Wang Z; Ran H; Li P; Ren J
Nano Lett; 2018 Mar; 18(3):1831-1841. PubMed ID: 29419305
[TBL] [Abstract][Full Text] [Related]
7. Low intensity focused ultrasound (LIFU) triggered drug release from cetuximab-conjugated phase-changeable nanoparticles for precision theranostics against anaplastic thyroid carcinoma.
Wang Y; Sui G; Teng D; Wang Q; Qu J; Zhu L; Ran H; Wang Z; Jin C; Wang H
Biomater Sci; 2018 Dec; 7(1):196-210. PubMed ID: 30422139
[TBL] [Abstract][Full Text] [Related]
8. Targeted tumor theranostics using folate-conjugated and camptothecin-loaded acoustic nanodroplets in a mouse xenograft model.
Chen WT; Kang ST; Lin JL; Wang CH; Chen RC; Yeh CK
Biomaterials; 2015; 53():699-708. PubMed ID: 25890765
[TBL] [Abstract][Full Text] [Related]
9. Phase-shift, targeted nanoparticles for ultrasound molecular imaging by low intensity focused ultrasound irradiation.
Li M; Luo H; Zhang W; He K; Chen Y; Liu J; Chen J; Wang D; Hao L; Ran H; Zheng Y; Wang Z; Li P
Int J Nanomedicine; 2018; 13():3907-3920. PubMed ID: 30013344
[TBL] [Abstract][Full Text] [Related]
10. Dual ultrasound-activatable nanodroplets for highly-penetrative and efficient ovarian cancer theranostics.
Yang C; Zhang Y; Luo Y; Qiao B; Wang X; Zhang L; Chen Q; Cao Y; Wang Z; Ran H
J Mater Chem B; 2020 Jan; 8(3):380-390. PubMed ID: 31868193
[TBL] [Abstract][Full Text] [Related]
11. Drug Release from Phase-Changeable Nanodroplets Triggered by Low-Intensity Focused Ultrasound.
Cao Y; Chen Y; Yu T; Guo Y; Liu F; Yao Y; Li P; Wang D; Wang Z; Chen Y; Ran H
Theranostics; 2018; 8(5):1327-1339. PubMed ID: 29507623
[No Abstract] [Full Text] [Related]
12. Targeted and pH-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (LIFU) with reduced side effect.
Liu Z; Ran H; Wang Z; Zhou S; Wang Y
Int J Nanomedicine; 2019; 14():7627-7642. PubMed ID: 31571868
[TBL] [Abstract][Full Text] [Related]
13. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
14. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
15. Effects of multiple injections on the efficacy and cytotoxicity of folate-targeted magnetite nanoparticles as theranostic agents for MRI detection and magnetic hyperthermia therapy of tumor cells.
Soleymani M; Khalighfard S; Khodayari S; Khodayari H; Kalhori MR; Hadjighassem MR; Shaterabadi Z; Alizadeh AM
Sci Rep; 2020 Feb; 10(1):1695. PubMed ID: 32015364
[TBL] [Abstract][Full Text] [Related]
16. pH- and acoustic-responsive platforms based on perfluoropentane-loaded protein nanoparticles for ovarian tumor-targeted ultrasound imaging and therapy.
Li J; Ji H; Jing Y; Wang S
Nanoscale Res Lett; 2020 Feb; 15(1):31. PubMed ID: 32016619
[TBL] [Abstract][Full Text] [Related]
17. A study of the synergistic effect of folate-decorated polymeric micelles incorporating Hydroxycamptothecin with radiotherapy on xenografted human cervical carcinoma.
You H; Fu S; Qin X; Yu Y; Yang B; Zhang G; Sun X; Feng Y; Chen Y; Wu J
Colloids Surf B Biointerfaces; 2016 Apr; 140():150-160. PubMed ID: 26752212
[TBL] [Abstract][Full Text] [Related]
18. Intracellular delivery of 10-hydroxycamptothecin with targeted nanostructured lipid carriers against multidrug resistance.
Liu M; Chen D; Mukerabigwi JF; Chen S; Zhang Y; Lei S; Luo S; Wen Z; Cao Y; Huang X; He H
J Drug Target; 2016; 24(5):433-40. PubMed ID: 26422582
[TBL] [Abstract][Full Text] [Related]
19. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.
Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y
Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Theranostic Potential of Perfluorohexane-Based Acoustic Nanodroplets.
Abdalkader R; Unga J; Yamashita F; Maruyama K; Hashida M
Biol Pharm Bull; 2019 Dec; 42(12):2038-2044. PubMed ID: 31554747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
